RB1 and neuroblastoma: In the case of RB, the p16/pRB pathway is inherently inactivated and BMI1 overexpression can be driven by increased E2F activity as demonstrated by binding of E2F1 on BMI1 promoter in human neuroblastoma cell lines (Nowak et al., 2006).